Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 4Unknown 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 264Glioblastoma 193Glioma 159Neuroblastoma 56Central Nervous System Neoplasms 55Astrocytoma 45Carcinoma, Non-Small-Cell Lung 39Neoplasms 32Breast Neoplasms 27Oligodendroglioma 26Meningioma 23Recurrence 21Neuroma, Acoustic 21Neoplasm Metastasis 20Meningeal Carcinomatosis 20Gliosarcoma 20Neurofibromatosis 1 18Medulloblastoma 18Lung Neoplasms 15Paraganglioma 14Lymphoma 14Pheochromocytoma 13Spinal Cord Neoplasms 12Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Burkitt Lymphoma 9Pancreatic Neoplasms 8Ovarian Neoplasms 7Melanoma 7Esophageal Neoplasms 7

Interventions

Fluorescein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cerebrovascular Disorders × CNS × Clear all
NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown
200 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡